Clinical Trials Browser

Glioblastoma

Recurrence, Triple Negative Breast Neoplasms

Colorectal Neoplasms

Carcinoma, Hepatocellular

Fallopian Tube Neoplasms, Ovarian Neoplasms

Advanced HCC

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Triple Negative Breast Neoplasms

Colorectal Neoplasms

Recurrent Liver Cancer After Liver Transplantation

Elderly Metastatic Colorectal Cancer Patients

Colorectal Neoplasms

Colorectal Neoplasms

Ovarian Neoplasms

Colorectal Neoplasms

Head and Neck Neoplasms

Colorectal Neoplasms

Colorectal Cancer Metastatic

Colorectal Neoplasms

Breast Neoplasms, Carcinoma, Renal Cell, Triple Negative Breast Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Squamous Cell Carcinoma of Head and Neck

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peripheral Nervous System Diseases

Advanced Metastatic Colorectal Cancer

Carcinoma, Hepatocellular

Colorectal Neoplasms

Ovarian Neoplasms

Glioblastoma

Carcinoma, Non-Small-Cell Lung

Breast Neoplasms

Bronchial Neoplasms, Carcinoma, Non-Small-Cell Lung

Bronchial Neoplasms, Carcinoma, Non-Small-Cell Lung

Ovarian Neoplasms

Ovarian Neoplasms

Non-squamous Non-small Cell Lung Cancer

Carcinoma, Hepatocellular

Mesothelioma, Malignant

Glioblastoma, Recurrence, Disease Progression

Carcinoma, Hepatocellular

Esophageal Squamous Cell Carcinoma

Adenocarcinoma Of Esophagus, Barrett Esophagus

Nasopharyngeal Carcinoma

Carcinoma, Non-Small-Cell Lung

Kidney Neoplasms, Lung Neoplasms, Melanoma

Biliary Tract Carcinoma

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

Clinical Trials

Sintilimab in Combination With Bevacizumab and Temozolomide in Recurrent Glioblastoma (GBM) Patients

BELLA

The Efficacy and Safety of Lcaritin Combined With Bevacizumab and FOLFIRI in Treatment of Liver Metastases From Colorectal Cancer

HCC

Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor

KD6001 in Combination With Anti-PD-1 Antibody±Bevacizumab in Patients With Advanced HCC and Other Solid Tumors

Real World Study on Erlotinib/Gefitinib Combined With Bevacizumab in Advanced Non-aquamous Non-small Cell Lung Cancer

Adebrelimab Combined With Bevacizumab and Docetaxel for Advanced Non-Squamous Non-small Cell Lung Cancer After Progression on First-line Immunotherapy

FUTURE-SUPER

DEBIRI

Hepatic Arterial Infusion Chemotherapy in Combination With Atezolizumab and Bevacizumab for Second-line Treatment of Patients With Recurrent Liver Cancer After Liver Transplantation

COBRA

AIO-KRK-0116

REVOLUTION

Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer

Envafolimab Combined With Trifluridine/Tipiracil and Bevacizumab in the Treatment of Refractory mCRC.

ATHENA

Phase 2 Study of CA102N Combined With TAS-102 Compared to Bevacizumab Combined With TAS-102 in Subjects With Relapsed and/or Refractory Metastatic Colorectal Cancer

POCHI

SIRTCI

MARIO-3

BEACON

Study of Chemotherapy Combination With Autologous Cell Immunotherapy in the Recurrent and Metastatic Colorectal Cancer

Sintilimab and Chidamide in Combination With or Without IBI305 in Advanced or Metastatic pMMR/MSS Colorectal Carcinoma

Calizumab Combined With Bevacizumab and Capecitabine in the Treatment of Head and Neck Squamous Cell Carcinoma

SELENIUM

SALIRI Based Regimen as First-line Treatment for Advanced Metastatic Colorectal Cancer

HAIC Plus A+T for Patients With High-risk HCC: a Single-arm Phase 2 Trial

QL1706 Monotherapy or in Combination With Bevacizumab and XELOX as First-line Treatment of Unresectable Advanced or Metastatic CRC

The Efficacy and Safety of The Fuzuloparib Combination With Bevacizumab

Efficacy and Safety of SCAI of Bevacizumab Combined With IC of Tislelizumab in the Treatment of Recurrent Glioblastoma.

Study of Atezolizumab Combination Carboplatin + Paclitaxel + Bevacizumab in EGRF Mutation or ALK Translocation NSCLC

A Phase Ⅰb/Ⅱ Clinical Study of SHR-A1811 Combined With Other Therapies in Patients With HER2 Low Advanced or Metastatic Breast Cancer.

Osimertinib Combined With Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions Metastatic Non-Small Cell Lung Cancer

Osimertinib Combined With Bevacizumab in Patients With Brain Metastasis Epidermal Growth Factor Receptor (EGFR) Mutation Positive Metastatic Non-Small Cell Lung Cancer

Phase II Study of Afatinib Plus Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon G719X, S768I, and L861Q Mutation Metastatic Non-Small Cell Lung Cancer

MITO16/MANGO-2

MITO16MANGO2b

BEVERLY

Sintilimab Combined With Bevacizumab and Liver Protective Support Therapy in Unresectable Hepatocellular Carcinoma

MiST

RE-GEND

Candonilimab Plus Bevacizumab for Patients With Advanced HCC Who Progressed on A+T

Tucidinostat Plus PD-1 Inhibitor and Bevacizumab for Advanced Esophagus Cancer, AEG, Gastric Cancer

SLURP

Efficacy and Safety of Sintilimab Plus Bevacizumab in Metastatic Nasopharyngeal Carcinoma After Failure of Platinum-based Chemotherapy: An Open-label Phase II Study

Adebrelimab Combined With Bevacizumab and Albumin Paclitaxel in Non-squamous NSCLC After First-line Treatment

Microbiome Immunotherapy Toxicity and Response Evaluation

Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab in Unresectable Biliary Tract Cancer

Serplulimab Combined With Anti-VEGF Antibody in Advanced Lung Adenocarcinoma